Vaxil Bio Ltd. (VXL.V)
0.16
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Vaxil Bio EPS Diluted (Quarterly) : -0.0161 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0161 |
| March 31, 2026 | -0.0269 |
| December 31, 2025 | 0.1451 |
| September 30, 2025 | -0.0073 |
| June 30, 2025 | 0.0153 |
| March 31, 2025 | -0.0255 |
| December 31, 2024 | -0.008 |
| September 30, 2024 | -0.018 |
| June 30, 2024 | -0.018 |
| March 31, 2024 | -0.0004 |
| December 31, 2023 | 0.0002 |
| September 30, 2023 | -0.0002 |
| June 30, 2023 | -0.0009 |
| March 31, 2023 | -0.0009 |
| December 31, 2022 | -0.0013 |
| September 30, 2022 | -0.001 |
| June 30, 2022 | -0.0011 |
| March 31, 2022 | -0.0009 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0018 |
| June 30, 2021 | -0.0016 |
| March 31, 2021 | -0.0019 |
| December 31, 2020 | -0.0055 |
| September 30, 2020 | -0.003 |
| June 30, 2020 | -0.003 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0019 |
| December 31, 2019 | -0.0055 |
| September 30, 2019 | -0.0023 |
| June 30, 2019 | -0.0023 |
| March 31, 2019 | -0.0028 |
| December 31, 2018 | -0.0045 |
| September 30, 2018 | -0.0026 |
| June 30, 2018 | -0.0021 |
| March 31, 2018 | -0.0037 |
| December 31, 2017 | -0.01 |
| September 30, 2017 | -0.01 |
| June 30, 2017 | -0.01 |
| March 31, 2017 | -0.01 |
| December 31, 2016 | -0.01 |
| September 30, 2016 | -0.01 |
| June 30, 2016 | -0.01 |
| March 31, 2016 | -0.11 |
| December 31, 2015 | -0.0087 |
| September 30, 2015 | -0.02 |
| November 30, 2014 | -0.02 |
| August 31, 2014 | -0.14 |
| May 31, 2014 | -0.0223 |
| February 28, 2014 | -0.0284 |
| November 30, 2013 | -0.0543 |
| August 31, 2013 | 0.0238 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.0039 |
| Quest PharmaTech, Inc. | 0.0201 |
| BriaCell Therapeutics Corp. | -1.354 |
| Waverley Pharma, Inc. | -0.0031 |
| Goldcoast Resource Corp. | -0.0725 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.064M |
| Total Expenses (Quarterly) | 0.064M |
| Enterprise Value | 0.1734M |
| Earnings Yield | 59.25% |
| Normalized Earnings Yield | -8.00 |